Lisa Russ Sinclair

Head of Corporate & Commercial Strategy at Rallybio

Lisa Russ Sinclair has over 28 years of experience in the pharmaceutical and biopharmaceutical industries. Lisa Russ began their career at Pfizer in 1993, where they held various roles such as Portfolio Group Head, Senior Director, Global Project Management Director, Lead Clinical Research Associate, and PRATT Pharmaceutical Sales Representative. In 2011, they joined AstraZeneca as Vice President of R&D Portfolio and Performance, where they were responsible for managing the R&D pipeline and lifecycle portfolios. In 2014, they joined Alexion Pharmaceuticals, Inc. as Vice President of R&D Strategy, Portfolio & Project Management, where they built and delivered new capabilities in R&D strategy, portfolio analysis, governance and program management. In 2018, they joined SpringWorks Therapeutics as Head of Program and Alliance Management, where they were accountable for alliance collaborations to advance life-changing medicines in cancer and severe rare diseases. In 2019, they joined Rallybio as Head of Corporate & Commercial Strategy. Currently, they are the SVP Corporate Operations at Arvinas.

Lisa Russ Sinclair received a BA in Business Administration with a focus in Marketing from the University of Vermont.

Links

Previous companies

SpringWorks Therapeutics logo
Pfizer logo
AstraZeneca logo
Alexion Pharmaceuticals logo

Timeline

  • Head of Corporate & Commercial Strategy

    October, 2019 - present